Delivery Order SPE2DB25D3006-SPE2DB25FXHER

Award Date 2/19/25
Potential Completion Date 3/12/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $6,370.00 and a completion date of February 13, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, with an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of BRUKINSA 80 MG CAPSULES 120S. The contract has a potential value of $6,765.08 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with the Defense Logistics Agency, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,242.15, is for the delivery of the drug BRUKINSA 80 MG CAPSULE 120S. This is a firm fixed-price delivery order contract with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, a specialty medication. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Brukinsa 80 mg capsules. The $7,492.44 firm fixed-price contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $7,242.15 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. This contract has an ultimate completion date of September 27, 2024. Amerisourcebergen, which operates through its Corporate Office division, is a large for-profit organization that provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $7,492.44, is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,242.15 firm fixed price delivery order is for the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S, with a period of performance through November 14, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,984.88 firm fixed-price delivery order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB25D3006
    Indefinite Delivery Contract
  • SPE2DB25D3006-SPE2DB25FXHER
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a medical product, with a ceiling value of $6,370.00 and a performance period through March 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside requirements indicated.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 9:59 AM